Water Street forms partnership with global health care company

Water Street Healthcare Partners has launched a pharmaceutical development partnership with an unnamed global health care company. As part of the joint venture, Water Street’s Capstone Development Solutions will develop generic products on behalf of its corporate health care partner. No financial terms were disclosed.


CHICAGO, May 27, 2015 /PRNewswire/ — Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, announced today that it has formed a pharmaceutical development partnership with one of the world’s leading global health care companies. The partnership expands Water Street’s pharmaceutical partnership program, which the firm established in 2013 as a new way to support corporations with leveraging their investment in developing pharmaceutical products and medical devices.

Water Street’s company Capstone Development Solutions (“Capstone”) will develop designated generic products on behalf of its newest corporate partner. Al Heller, former CEO of American Pharmaceutical Partners Inc. (APPI) and an operating partner with Water Street, will serve as chairman. Dan Robins, Ph.D., who has more than 20 years of experience in pharmaceutical research and development, will oversee Capstone’s team of scientists and regulatory experts. Once the designated products receive regulatory approval, Capstone will be compensated at a previously agreed-upon price.

“We are honored that another health care leader has entrusted us with developing its pharmaceutical products and supporting its commitment to launch new, affordable drugs,” said Mr. Heller. “We created this program as a new model to enable companies to bring more products to market, more quickly and efficiently. We look forward to working with more corporations to customize solutions through Capstone that advance their long-term goals.”

The partnership marks Water Street’s seventh investment in the pharmaceutical sector in the past six years and second investment in 2015. The health care firm acquired generic injectable drug services company Custopharm, Inc. earlier this year.

About Water Street
Water Street is a strategic investor focused exclusively on health care. The firm has a strong record of building market-leading companies across key growth sectors in health care. It has worked with some of the world’s leading health care companies on its investments including Johnson & Johnson, Medtronic, Smith & Nephew and Walgreen Co. Water Street’s team is comprised of industry executives and private equity professionals with decades of experience investing in and operating global health care businesses. The firm is headquartered in Chicago. For more information about Water Street, visit waterstreet.com.